Sign in
Taking peopleNo phase

Checking a clot risk score in people with leg injuries needing a cast

Tests a risk score for blood clots in adults with immobilized leg injuries.

Key facts

Who runs it
University of Monastir
Where
Tunisia1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
TRiP-cast Score Validation and Evaluation of Adherence to Preventive Anticoagulant Treatment in Patients With Lower Limb Trauma Requiring Immobilization
Status
Recruiting
People taking part
1,500 people, planned
Started
1 Sept 2025
Expected to end
31 Dec 2028
Type of study
Observational, 3 groups
Treatments tested
  • Low-Molecular-Weight Heparin (LMWH)
  • Direct Oral Anticoagulants (DOACs)
  • No Thromboprophylaxis Cohort
Record updated
7 October 2026

Who can take part

The trial is looking for adults with a recent leg injury that needs a cast or rigid brace, treated without a hospital stay. It studies a score for blood clot risk and how well people take clot-preventing medicine.

Age
18 years or older
Sex
All sexes
Disease stage
Acute lower-limb injury within 72 hours before joining: a fracture (for example foot, ankle, leg or lower thigh bone), a grade II or III ankle or knee sprain, or an acute Achilles tendon tear treated without surgery. A cast or rigid brace (splint or walking boot) is expected for at least 7 days. Care starts in an emergency department or outpatient clinic, with no planned hospital stay over 24 hours.
Earlier treatment
People cannot already be taking blood-thinning medicine (by mouth or injection) for another reason.
Main reasons for not taking part
  • Hospital stay of more than 24 hours, planned or at the start
  • A blood clot in a vein or lung in the previous 3 months
  • Serious reasons not to take blood thinners, such as active bleeding, untreated active stomach ulcer, platelet count <50,000/mm³, severe liver problems, or creatinine clearance <30 mL/min
  • Open leg wound injury that needs surgery right away
  • Pregnancy or breastfeeding
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • Age ≥18 years
  • Acute lower-limb trauma within 72 hours before enrollment:; Fracture (e.g., foot, ankle, leg, or distal femur) requiring immobilization, or; Grade II or III ankle or knee sprain requiring immobilization, or; Acute Achilles tendon rupture requiring immediate non-surgical immobilization
  • Immobilization with a cast or rigid orthosis (e.g., splint or walking boot) expected to last at least 7 days
  • Initial outpatient management in an emergency department or outpatient orthopedic/trauma clinic
  • No planned hospitalization exceeding 24 hours for the injury or its immediate complications
  • Written informed consent provided before study enrollment

Who cannot take part

  • History of venous thromboembolism within the previous 3 months
  • Current oral or injectable anticoagulant therapy for another indication
  • Open lower-limb trauma requiring immediate surgery (except simple fracture reduction and immobilization)
  • Concurrent participation in another clinical study that may interfere with the objectives of the present study
  • Known major contraindication to anticoagulant therapy, including:; Active bleeding; Untreated active peptic ulcer disease; Severe thrombocytopenia (platelet count <50,000/mm³); Severe hepatic impairment; Severe renal impairment (estimated creatinine clearance <30 mL/min using the CKD-EPI equation)
  • Planned or initial hospitalization for more than 24 hours
  • Inability to understand the study procedures or provide written informed consent
  • Pregnancy or breastfeeding

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age

This trial is currently available in Tunisia.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a prospective, multicenter, observational cohort study designed to externally validate the Trauma-Related Immobilization-related Prophylaxis (TRiP(cast)) score in Tunisian adults with acute lower-limb trauma requiring immobilization and managed as outpatients. The study will assess the ability of the TRiP(cast) score to identify patients at increased risk of symptomatic venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism.

Read full original descriptionShow less

A secondary objective is to evaluate adherence to prescribed thromboprophylaxis and to compare adherence between patients receiving low-molecular-weight heparin (LMWH) and those receiving direct oral anticoagulants (DOACs). Factors associated with treatment adherence, bleeding events, and thromboembolic outcomes will also be investigated.

Patients aged 18 years or older with acute lower-limb trauma requiring immobilization for at least 7 days will be enrolled consecutively and followed prospectively. The decision to prescribe thromboprophylaxis and the choice of anticoagulant will remain entirely at the discretion of the treating physician according to routine clinical practice. Study investigators will not influence treatment decisions. The results are expected to provide external validation of the TRiP(cast) score in the Tunisian population and improve risk stratification and thromboprophylaxis management in ambulatory patients with lower-limb trauma.

The 3 groups in the trial

  • LMWH Cohort

    Participants with acute lower-limb trauma requiring immobilization who are prescribed low-molecular-weight heparin (LMWH) for venous thromboembolism prophylaxis according to routine clinical practice.

    Treatment: Low-Molecular-Weight Heparin (LMWH)

  • DOAC Cohort

    Participants with acute lower-limb trauma requiring immobilization who are prescribed a direct oral anticoagulant (DOAC) for venous thromboembolism prophylaxis according to routine clinical practice.

    Treatment: Direct Oral Anticoagulants (DOACs)

  • No Thromboprophylaxis Cohort

    Participants who do not receive pharmacological thromboprophylaxis because the treating physician determines that anticoagulation is not indicated according to routine clinical practice.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Validation of the TRiP-cast Score and Evaluation of Adherence to Preventive Anticoagulant Treatment in Non-Hospitalized Patients With Lower Limb Trauma Requiring Immobilization
Plain-language title
Checking a clot risk score in people with leg injuries needing a castGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07863115, who can take part
Record updated
7 October 2026